InvestorsHub Logo
icon url

Rdunn88

01/08/18 12:27 PM

#211932 RE: cabel #211931

Maybe not being more critical has been the main problem? Leo continues to brush off the financials when asked, but has no solution... His strategy "3 years ago" was non-partnership, dilute the shares and build 3 drugs past phase 3. What has not happened is stock appreciation to offset Aspire's continued onslaught. So now, Leo is fully dependable on partnership/sale to survive. Time is running out on the 11 year "next Regeneron" dream...